STOCKHOLM, Dec. 19, 2023 /PRNewswire/ --
As announced on December
15, 2023, Essity will, as of the fourth quarter of
2023, classify the financial reporting of Vinda as discontinued
operations. Today, Essity is publishing updated comparable figures
to reflect this change in accounting.
EARNINGS TREND
|
SEKm
|
2023:3
|
2023:2
|
2023:1
|
2022:4
|
2212
|
2112
|
|
Net sales
|
37,092
|
37,078
|
36,352
|
36,629
|
131,320
|
101,466
|
|
Gross profit
|
10,683
|
10,454
|
10,359
|
9,935
|
32,026
|
29,144
|
|
Adjusted gross
profit1
|
11,670
|
10,809
|
10,321
|
10,237
|
33,925
|
29,290
|
|
Adjusted operating
profit before amortization of acquisition- related intangible
assets (EBITA)1
|
5,147
|
4,617
|
4,281
|
4,112
|
12,047
|
11,451
|
|
Operating profit before
amortization of acquisition-related intangible assets
(EBITA)
|
3,497
|
4,131
|
4,368
|
3,818
|
9,876
|
11,822
|
|
Amortization of
acquisition-related intangible assets
|
-277
|
-279
|
-283
|
-288
|
-1,111
|
-844
|
|
Adjusted operating
profit1
|
4,870
|
4,338
|
3,998
|
3,824
|
10,936
|
10,607
|
|
Items affecting
comparability
|
-1,967
|
-519
|
87
|
-305
|
-2,445
|
371
|
|
Operating
profit
|
2,903
|
3,819
|
4,085
|
3,519
|
8,491
|
10,978
|
|
Financial
items
|
-644
|
-588
|
-625
|
-561
|
-1,320
|
-567
|
|
Profit before
tax
|
2,259
|
3,231
|
3,460
|
2,958
|
7,171
|
10,411
|
|
Adjusted profit before
tax1
|
4,226
|
3,750
|
3,373
|
3,263
|
9,616
|
10,040
|
|
Income taxes
|
-696
|
-786
|
-809
|
-736
|
-2,006
|
-2,398
|
|
Profit for the period
from continuing operations
|
1,563
|
2,445
|
2,651
|
2,222
|
5,165
|
8,013
|
|
Profit for the period
from discontinued operations
|
88
|
106
|
52
|
24
|
899
|
1,797
|
|
Profit for the period,
total operations
|
1,651
|
2,551
|
2,703
|
2,246
|
6,064
|
9,810
|
|
Earnings per share
before and after dilution, continuing operation, SEK
|
2.20
|
3.46
|
3.75
|
3.14
|
7.28
|
10.96
|
|
Adjusted earnings per
share before and after dilution, continuing
operation, SEK2
|
4.83
|
4.26
|
3.93
|
3.75
|
11.60
|
11.18
|
|
Earnings per share
before and after dilution, total operations, SEK
|
2.26
|
3.53
|
3.79
|
3.15
|
7.93
|
12.27
|
|
1Excluding items
affecting comparability.
|
|
|
|
|
|
|
|
2Excluding items
affecting comparability and amortization of acquisition-related
intangible assets.
|
|
|
NET SALES BY BUSINESS AREA
|
SEKm
|
2023:3
|
2023:2
|
2023:1
|
2022:4
|
2212
|
2112
|
|
Health &
Medical
|
7,158
|
6,905
|
6,665
|
6,589
|
24,708
|
21,255
|
|
Consumer
Goods
|
19,729
|
20,056
|
20,257
|
20,454
|
72,241
|
55,821
|
|
Professional
Hygiene
|
10,184
|
10,123
|
9,422
|
9,617
|
34,393
|
24,392
|
|
Other
|
21
|
-6
|
8
|
-31
|
-22
|
-2
|
|
Total
|
37,092
|
37,078
|
36,352
|
36,629
|
131,320
|
101,466
|
ORGANIC SALES GROWTH BY BUSINESS AREA
|
( %)
|
2023:3
|
2023:2
|
2023:1
|
2022:4
|
2212
|
2112
|
|
Health &
Medical
|
5.8
|
8.0
|
10.6
|
4.5
|
7.2
|
5.5
|
|
Consumer
Goods
|
-0.4
|
5.7
|
14.8
|
18.4
|
17.6
|
0.2
|
|
Professional
Hygiene
|
5.7
|
11.7
|
22.6
|
20.7
|
25.4
|
5.8
|
|
Total
|
2.4
|
7.7
|
15.9
|
16.0
|
17.3
|
2.6
|
SALES GROWTH, INCLUDING ORGANIC SALES GROWTH AND
ACQUISITIONS BY BUSINESS AREA
|
( %)
|
2023:3
|
2023:2
|
2023:1
|
2022:4
|
2212
|
2112
|
|
Health &
Medical
|
5.8
|
8.0
|
10.6
|
6.4
|
9.6
|
6.6
|
|
Consumer
Goods
|
1.1
|
8.7
|
17.2
|
21.1
|
20.0
|
1.6
|
|
Professional
Hygiene
|
5.7
|
11.7
|
22.9
|
21.3
|
27.7
|
7.7
|
|
Total
|
3.3
|
9.3
|
17.4
|
18.0
|
19.7
|
4.0
|
|
|
|
|
|
|
|
ADJUSTED EBITA BY BUSINESS AREA
|
SEKm
|
2023:3
|
2023:2
|
2023:1
|
2022:4
|
2212
|
2112
|
|
Health &
Medical
|
1,188
|
947
|
777
|
719
|
2,904
|
3,800
|
|
Consumer
Goods
|
2,395
|
2,417
|
2,400
|
2,293
|
6,354
|
5,767
|
|
Professional
Hygiene
|
1,887
|
1,582
|
1,288
|
1,405
|
3,843
|
2,673
|
|
Other
|
-323
|
-329
|
-184
|
-305
|
-1,054
|
-789
|
|
Total
|
5,147
|
4,617
|
4,281
|
4,112
|
12,047
|
11,451
|
ADJUSTED OPERATING PROFIT BY BUSINESS AREA
|
SEKm
|
2023:3
|
2023:2
|
2023:1
|
2022:4
|
2212
|
2112
|
|
Health &
Medical
|
979
|
737
|
560
|
499
|
2,058
|
3,082
|
|
Consumer
Goods
|
2,332
|
2,356
|
2,338
|
2,231
|
6,109
|
5,650
|
|
Professional
Hygiene
|
1,881
|
1,577
|
1,282
|
1,400
|
3,823
|
2,663
|
|
Other
|
-322
|
-332
|
-182
|
-306
|
-1,054
|
-788
|
|
Total adjusted
operating profit1
|
4,870
|
4,338
|
3,998
|
3,824
|
10,936
|
10,607
|
|
Financial
items
|
-644
|
-588
|
-625
|
-561
|
-1,320
|
-567
|
|
Profit before
tax1
|
4,226
|
3,750
|
3,373
|
3,263
|
9,616
|
10,040
|
|
Income taxes
|
-995
|
-941
|
-803
|
-815
|
-2,206
|
-2,474
|
|
Net profit for the
period2
|
3,231
|
2,809
|
2,570
|
2,448
|
7,410
|
7,566
|
|
|
|
|
|
|
|
|
1Excluding items
affecting comparability before tax amounting to:
|
-1,967
|
-519
|
87
|
-305
|
-2,445
|
371
|
|
2Excluding items
affecting comparability after tax amounting to:
|
-1,668
|
-364
|
81
|
-226
|
-2,245
|
447
|
ADJUSTED EBITA MARGIN BY BUSINESS AREA
|
( %)
|
2023:3
|
2023:2
|
2023:1
|
2022:4
|
2212
|
2112
|
|
Health &
Medical
|
16.6
|
13.7
|
11.7
|
10.9
|
11.8
|
17.9
|
|
Consumer
Goods
|
12.1
|
12.1
|
11.8
|
11.2
|
8.8
|
10.3
|
|
Professional
Hygiene
|
18.5
|
15.6
|
13.7
|
14.6
|
11.2
|
11.0
|
|
Total
|
13.9
|
12.5
|
11.8
|
11.2
|
9.2
|
11.3
|
ADJUSTED GROSS MARGIN BY BUSINESS AREA
|
( %)
|
2023:3
|
2023:2
|
2023:1
|
2022:4
|
2212
|
2112
|
|
Health &
Medical
|
42.0
|
39.0
|
37.8
|
36.3
|
37.4
|
42.7
|
|
Consumer
Goods
|
28.3
|
26.3
|
26.3
|
25.7
|
23.0
|
25.7
|
|
Professional
Hygiene
|
30.2
|
28.1
|
26.3
|
26.8
|
23.4
|
24.0
|
|
Total
|
31.5
|
29.2
|
28.4
|
27.9
|
25.8
|
28.9
|
ADJUSTED RETURN ON CAPITAL EMPLOYED BY BUSINESS AREA
|
( %)
|
2023:3
|
2023:2
|
2023:1
|
2022:4
|
2212
|
2112
|
|
Health &
Medical
|
13.3
|
10.7
|
9.1
|
8.3
|
8.7
|
12.8
|
|
Consumer
Goods
|
17.2
|
17.6
|
18.2
|
16.7
|
12.8
|
14.2
|
|
Professional
Hygiene
|
28.0
|
22.7
|
18.6
|
19.3
|
14.0
|
11.7
|
|
Total
|
17.2
|
15.8
|
15.2
|
13.9
|
10.9
|
12.4
|
OPERATING CASH FLOW BY BUSINESS AREA
|
SEKm
|
2023:3
|
2023:2
|
2023:1
|
2022:4
|
2212
|
2112
|
|
Health &
Medical
|
1,676
|
323
|
270
|
818
|
2,396
|
3,834
|
|
Consumer
Goods
|
2,235
|
1,732
|
1,760
|
1,043
|
3,567
|
5,152
|
|
Professional
Hygiene
|
2,370
|
1,782
|
951
|
1,344
|
3,219
|
2,311
|
|
Other
|
-227
|
-990
|
-111
|
-585
|
-1,503
|
-1,552
|
|
Total
|
6,054
|
2,847
|
2,870
|
2,620
|
7,679
|
9,745
|
NET SALES BY CATEGORY
|
( %)
|
2212
|
|
Health &
Medical
|
19
|
|
of which
|
|
|
Incontinence
Products Health Care
|
11
|
|
Medical
Solutions
|
8
|
|
Consumer
Goods
|
55
|
|
of which
|
|
|
Incontinence
Products Retail
|
7
|
|
Feminine
Care
|
8
|
|
Baby
Care
|
5
|
|
Consumer
Tissue
|
35
|
|
Professional
Hygiene
|
26
|
NET SALES PER REGION
|
( %)
|
2212
|
|
Europe
|
62
|
|
Latin
America
|
16
|
|
North
America
|
16
|
|
Asia
|
2
|
|
Other
|
4
|
For further information, please contact:
Per Lorentz, Vice President Corporate Communications, +46
73 313 30 55, per.lorentz@essity.com
Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89,
sandra.aberg@essity.com
The following files are available for download:
|
https://mb.cision.com/Main/15798/3896297/2504980.pdf
|
Essity reports Vinda as
discontinued operations as of Q4 2023 and publishes updated
comparable figures
|
View original
content:https://www.prnewswire.co.uk/news-releases/essity-reports-vinda-as-discontinued-operations-as-of-q4-2023-and-publishes-updated-comparable-figures-302019271.html
